Clinical trial delays often originate in early site selection decisions, where misalignment between protocol demands and site capabilities undermines startup, enrollment, and data quality despite later efforts to correct course.
Denise McNerney
Advertisement
Denise McNerney is a Partner at Global Life Sciences Alliance (GLSA), where she works across sponsors, CROs, and research sites to support study feasibility, site selection, and clinical trial execution. Her work focuses on building strategic connections across the clinical research ecosystem to help organizations navigate operational complexity and bring studies forward more effectively.
Articles by Denise McNerney
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
3
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
4
SCOPE X: What Real-Time Patient Data Is Doing to ClinOps Efficiency
5